Fundraising

Established firms with ancillary strategies have at times struggled to attract capital for those funds outside of their core vehicles, and some have chosen to put parallel strategies on hold.

The investors include public and corporate pension plans, sovereign wealth funds, insurance companies, endowment funds, foundations, and individual investors in the private wealth category.

InTandem Capital Partners Fund III will invest in North American payor, provider, and pharmaceutical services businesses.

The firm has increasingly been raising capital from separate mandates and from individual investors via evergreen products.

Harlan Special Opportunities Fund V surpasses its predecessor, HSOF IV, which raised approximately $115 million.

Inovia Growth Fund III held the close this month and will now focus on raising the rest of its $450m target, CEO Chris Arsenault told Buyouts, with a final close expected before the fall.

LPs include Mubadala Investment Co, tech investor Yuri Milner, Bolt Ventures, Boxfish Corp, Ferguson Capital II, Lakefield Enterprises III, NJF Capital Corp and RIT Capital Partners.

Summit is targeting slightly more for Fund XII compared to its predecessor, wrapped up three years ago at $8.35bn.

Aquiline Financial Services Fund V has over $2.3 billion in capital commitments while Aquiline closed on about $1.1 billion for its continuation fund.

Fund V will provide mezzanine capital to middle-market businesses, continuing its strategy from prior funds.